Leading to cancer, aging, or both, somatic mutations are usually detrimental to the individual. Mutations at the immunoglobulin (Ig) loci are an exception, because they generate high affinity antibodies, which are important in memory responses to pathogens. Thus, in the segments of immunoglobulin genes that encode the variable (V) regions of antibodies, mutations are beneficial. Since such mutations arise at a million times higher rate than the normal, spontaneous mutation rate at other loci, the process is called hypermutation. Due to its high rate and to its being focused to a few loci, hypermutation allows easier access to the proximate causes of mutation and may thus serve as a model system for studies of the mutational process in general. Hypermutation is catalyzed by the putative immunoglobulin mutator system, or """"""""mutator"""""""". This mutator is thought to put an imbalance onto the general DNA error repair system. The sequences that target the action of the mutator to the immunoglobulin locus ( enhancers) differ from the sequences where the mutator action is seen (the V (D) J segments and their flanking sequences). Furthermore, within the sequences to be mutated, there are short stretches that are even more mutable than the others, and these so-called hot spots may represent sequence motifs. The objective of this application is to define, in an in vitro transfection system as well as in vivo, cis and trans-acting element for hypermutation at the immunoglobulin loci. Specifically, (I) the role of the enhancer in the major intron as well as other other intronic sequences at the immunoglobulin heavy-chain locus will be defined; (ii) the target base pairs, or hot spot motifs, within the V regions will be identified; and (III) mutation frequencies and profiles will be assessed in monoclonal mice with and without a mismatch repair deficiency.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM037699-13
Application #
6179501
Study Section
Immunobiology Study Section (IMB)
Program Officer
Wolfe, Paul B
Project Start
1987-04-01
Project End
2001-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
13
Fiscal Year
2000
Total Cost
$283,988
Indirect Cost
Name
University of California San Francisco
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Borggrefe, T; Keshavarzi, S; Gross, B et al. (2001) Impaired IgE response in SWAP-70-deficient mice. Eur J Immunol 31:2467-75
Masat, L; Liddell, R A; Mock, B A et al. (2000) Mapping of the SWAP70 gene to mouse chromosome 7 and human chromosome 11p15. Immunogenetics 51:16-9
Masat, L; Caldwell, J; Armstrong, R et al. (2000) Association of SWAP-70 with the B cell antigen receptor complex. Proc Natl Acad Sci U S A 97:2180-4
Borggrefe, T; Masat, L; Wabl, M et al. (1999) Cellular, intracellular, and developmental expression patterns of murine SWAP-70. Eur J Immunol 29:1812-22
Wabl, M; Cascalho, M; Steinberg, C (1999) Hypermutation in antibody affinity maturation. Curr Opin Immunol 11:186-9
Borggrefe, T; Wabl, M; Akhmedov, A T et al. (1998) A B-cell-specific DNA recombination complex. J Biol Chem 273:17025-35
Cascalho, M; Wong, J; Steinberg, C et al. (1998) Mismatch repair co-opted by hypermutation. Science 279:1207-10
Bachl, J; Olsson, C; Chitkara, N et al. (1998) The Ig mutator is dependent on the presence, position, and orientation of the large intron enhancer. Proc Natl Acad Sci U S A 95:2396-9
Bachl, J; Steinberg, C; Wabl, M (1997) Critical test of hot spot motifs for immunoglobulin hypermutation. Eur J Immunol 27:3398-403
Cascalho, M; Wong, J; Wabl, M (1997) VH gene replacement in hyperselected B cells of the quasimonoclonal mouse. J Immunol 159:5795-801

Showing the most recent 10 out of 30 publications